EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients

Daan Kremer, Dion Groothof iD, Sovia Salamah iD, Adrian Post iD, Tim J Knobbe iD, Sarah Peterson iD, Marco van Londen iD, Murthy Yerramilli, Stefan P Berger iD, Firas F Alkaff iD, Stephan J L Bakker iD

Kidney360 · 2026-08 · 7 (8) · 1873-1879

DOI: 10.34067/kid.0000001204 ↗

At a glance

Journal article in Kidney360, published online on 2026-05-04. Written by Daan Kremer and 10 co-authors. Institution: Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Major MEDLINE topics: Kidney Transplantation, Arginine. 19 references. The full text is freely available (open access, CC BY 4.0). Funded by: Top Institute Food and Nutrition.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Key Points In this large cohort of kidney transplant recipients, plasma symmetric dimethylarginine concentrations were independently associated with a higher mortality risk Symmetric dimethylarginine may not merely be an inert uremic solute and may be involved as a uremic toxin in ongoing pathological processes Background Long-term outcome after kidney transplantation remains limited because of high risks of cardiovascular, infectious, and malignant premature death. Uremic solutes, such as urea and symmetric dimethylarginine (SDMA), are suggested to contribute to higher oxidative stress, chronic low-grade inflammation, and excess mortality. Therefore, we evaluated the associations of urea and SDMA with all-cause and cause-specific mortality in kidney transplant recipients.

Methods

Baseline plasma SDMA was measured using liquid chromatography-mass spectrometry in kidney transplant recipients enrolled in the prospective TransplantLines Food and Nutrition Biobank and Cohort Study (Groningen, The Netherlands). We assessed prospective associations of SDMA with all-cause and cause-specific mortality using Cox regression.

Results

We included 628 adult kidney transplant recipients (56% male, age, 53±13 years; eGFR, 52±20 ml/min per 1.73 m 2 ) at 5.4 [interquartile range, 1.8–12.0] years after transplantation. Median plasma urea was 9.6 [7.3–13.4] mmol/L, and plasma SDMA was 20 [15–25] µ g/dl. In Cox regression analyses, both plasma urea (hazard ratio per doubling, 2.21; 95% confidence interval, 2.22 to 2.85) and plasma SDMA (hazard ratio per doubling, 2.69; 95% confidence interval, 1.95 to 3.70) were strongly associated with a higher risk of all-cause mortality. These associations remained for SDMA but not urea in a fully adjusted model, and the observed associations were generally similar for all causes of death.

Conclusions

Plasma urea and SDMA are both associated with a higher mortality risk in outpatient kidney transplant recipients. In a model including both urea and SDMA, only the association of SDMA with mortality remained. Clinical Trial registry name and registration number: NCT02811835.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationArginineHumansMaleProspective StudiesFemaleMiddle AgedAdultUreaBiomarkersNetherlandsCohort StudiesTransplant Recipients

Author keywords

cardiovascular diseasechronic inflammationclinical sciencekidney transplantationmortalityoxidative stressrenal transplantationureauremia

Substances

Argininesymmetric dimethylarginineUreaBiomarkers

Authors and institutions

  • Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Public Health and Preventive Medicine, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
  • IDEXX Laboratories, Inc, One IDEXX Drive, Westbrook, Maine.
  • Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.

ORCID profiles: Dion Groothof, Sovia Salamah, Adrian Post, Tim J Knobbe, Sarah Peterson, Marco van Londen, Stefan P Berger, Firas F Alkaff, Stephan J L Bakker

Funding

  • Top Institute Food and Nutrition

Cite

APA

Kremer, D., Groothof, D., Salamah, S., Post, A., Knobbe, T. J., Peterson, S., van Londen, M., Yerramilli, M., Berger, S. P., Alkaff, F. F., & Bakker, S. J. L. (2026). Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients. Kidney360, 7(8), 1873-1879. https://doi.org/10.34067/kid.0000001204

Vancouver

Kremer D, Groothof D, Salamah S, Post A, Knobbe TJ, Peterson S, et al. Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients. Kidney360. 2026;7(8):1873-1879. doi:10.34067/kid.0000001204

BibTeX
@article{Kremer2026,
  author = {Kremer, Daan and Groothof, Dion and Salamah, Sovia and Post, Adrian and Knobbe, Tim J and Peterson, Sarah and van Londen, Marco and Yerramilli, Murthy and Berger, Stefan P and Alkaff, Firas F and Bakker, Stephan J L},
  title = {Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {8},
  pages = {1873--1879},
  doi = {10.34067/kid.0000001204}
}
Start for free →